Becky Leung, Hnin Aung, A. Nandini, Ghusoon Abdulrasool, Chiyan Lau, Louise Seymour
{"title":"分析验证骨髓恶性肿瘤的 37 个基因新一代测序面板并审查初步结果,包括根据 2022 年世界卫生组织/国际癌症中心/骨髓增生异常综合征指南对急性髓性白血病和骨髓增生异常综合征进行重新分类","authors":"Becky Leung, Hnin Aung, A. Nandini, Ghusoon Abdulrasool, Chiyan Lau, Louise Seymour","doi":"10.1016/j.jmoldx.2024.01.010","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":501605,"journal":{"name":"The Journal of Molecular Diagnostics","volume":"240 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Analytical validation of a 37-gene next generation sequencing panel for myeloid malignancies and review of initial findings, including reclassification of Acute Myeloid Leukemias and Myelodysplastic Syndromes using the 2022 WHO/ICC/ELN guidelines\",\"authors\":\"Becky Leung, Hnin Aung, A. Nandini, Ghusoon Abdulrasool, Chiyan Lau, Louise Seymour\",\"doi\":\"10.1016/j.jmoldx.2024.01.010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":501605,\"journal\":{\"name\":\"The Journal of Molecular Diagnostics\",\"volume\":\"240 \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of Molecular Diagnostics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jmoldx.2024.01.010\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Molecular Diagnostics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jmoldx.2024.01.010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Analytical validation of a 37-gene next generation sequencing panel for myeloid malignancies and review of initial findings, including reclassification of Acute Myeloid Leukemias and Myelodysplastic Syndromes using the 2022 WHO/ICC/ELN guidelines